The Sensing Liver: Localization and Ligands

感知肝脏:定位和配体

基本信息

  • 批准号:
    10093039
  • 负责人:
  • 金额:
    $ 11.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-02-01 至 2023-01-31
  • 项目状态:
    已结题

项目摘要

Project Summary Sensory receptors are seven transmembrane domain G protein-coupled chemoreceptors (GPCRs) that govern one’s sensation and interpretation of their surrounding world. These receptors, that include olfactory receptors (ORs), taste receptors (TRs), opsins, and other understudied sensory GPCRs (GPRs), are expressed throughout the body where they help to regulate diverse physiological functions. In work funded by a K01 grant (DK106400), we found that one of these receptors, Olfr1393, is expressed in a variety of tissues including the kidney, liver, and small intestine where it contributes to the regulation of glucose reabsorption and the progression of diabetes. To identify additional sensory receptors that may also modulate metabolic function, we screened the liver, the largest metabolic organ in the body, using qPCR gene expression array cards. To date, we have found a total of 86 sensory receptors expressed in murine liver, and have narrowed down the list to 13 ‘highly expressed’ receptors. The aim of this grant is to completely characterize these receptors. To do so, we must understand where they are found (both at the cellular and subcellular level) and identify their ligand profile. The data acquired from this R03 proposal will uncover promising new leads that will assist us in determining the functions that these sensory receptors have in both health and disease.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Blythe D Shepard其他文献

Blythe D Shepard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Blythe D Shepard', 18)}}的其他基金

Hepatic GPR125: ligands and liver repair
肝脏 GPR125:配体和肝脏修复
  • 批准号:
    10452011
  • 财政年份:
    2022
  • 资助金额:
    $ 11.7万
  • 项目类别:
Elucidating the Role of Olfactory Receptor 1393 in Renal Glucose Handling
阐明嗅觉受体 1393 在肾葡萄糖处理中的作用
  • 批准号:
    10440017
  • 财政年份:
    2016
  • 资助金额:
    $ 11.7万
  • 项目类别:
Renal Olfactory Receptor 1393: Ligands, Localization and Function
肾嗅觉受体 1393:配体、定位和功能
  • 批准号:
    8397867
  • 财政年份:
    2012
  • 资助金额:
    $ 11.7万
  • 项目类别:
Renal Olfactory Receptor 1393: Ligands, Localization and Function
肾嗅觉受体 1393:配体、定位和功能
  • 批准号:
    8700391
  • 财政年份:
    2012
  • 资助金额:
    $ 11.7万
  • 项目类别:
Renal Olfactory Receptor 1393: Ligands, Localization and Function
肾嗅觉受体 1393:配体、定位和功能
  • 批准号:
    8511352
  • 财政年份:
    2012
  • 资助金额:
    $ 11.7万
  • 项目类别:

相似海外基金

A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
  • 批准号:
    24K02286
  • 财政年份:
    2024
  • 资助金额:
    $ 11.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
  • 批准号:
    2420924
  • 财政年份:
    2024
  • 资助金额:
    $ 11.7万
  • 项目类别:
    Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 11.7万
  • 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
  • 批准号:
    10742028
  • 财政年份:
    2023
  • 资助金额:
    $ 11.7万
  • 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
  • 批准号:
    BB/X017540/1
  • 财政年份:
    2023
  • 资助金额:
    $ 11.7万
  • 项目类别:
    Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
  • 批准号:
    LP210301365
  • 财政年份:
    2023
  • 资助金额:
    $ 11.7万
  • 项目类别:
    Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
  • 批准号:
    10730832
  • 财政年份:
    2023
  • 资助金额:
    $ 11.7万
  • 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
  • 批准号:
    10659841
  • 财政年份:
    2023
  • 资助金额:
    $ 11.7万
  • 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
  • 批准号:
    BB/V016067/1
  • 财政年份:
    2022
  • 资助金额:
    $ 11.7万
  • 项目类别:
    Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
  • 批准号:
    576545-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 11.7万
  • 项目类别:
    Idea to Innovation
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了